
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
Description
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
The Blood Testing Market size was estimated at USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030.
Blood testing is a clinical procedure that involves analyzing a blood sample in a laboratory to assess the general state of health, detect the presence of viral or bacterial infections, determine the functioning of various organs, and screen for genetic conditions. Blood tests are critical tools for preventive medicine and medical diagnostics, providing valuable data for early disease detection and management. Blood tests have various applications in various medical and healthcare domains. Routine testing for metabolic functions, increasing prevalence of infectious disease, and ongoing investments in blood testing facilities have enhanced the need for advanced blood testing solutions. However, strict regulatory requirements for approval and high costs associated with advanced testing technologies may restrict product penetration worldwide. In addition, a lack of trained professionals to conduct and interpret complex blood tests may limit the use of blood testing solutions. Nevertheless, the improved testing technologies that provide quicker, more accurate, and less invasive testing and Increased spending on healthcare infrastructure and diagnostics are expected to create growth opportunities for the blood testing market in the coming years.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
190 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of autoimmune disorders among individuals and need for enhanced care
- 5.1.1.2. Government initiatives in blood testing checkup campaigns
- 5.1.1.3. Significant expansion of blood testing facilities worldwide
- 5.1.2. Restraints
- 5.1.2.1. Changing costs of raw materials and issues of product recalls
- 5.1.3. Opportunities
- 5.1.3.1. Rapid adoption of home-based healthcare and telemedicine
- 5.1.3.2. Advancements in blood testing products
- 5.1.4. Challenges
- 5.1.4.1. Inaccuracy in skin puncture and safety issues associated with blood testing products
- 5.2. Market Segmentation Analysis
- 5.2.1. Type: Significant penetration of basic metabolic panels for blood testing
- 5.2.2. Application: Rising usage of blood testing kits for diagnosis of autoimmune diseases
- 5.2.3. End-User: Emerging penetration of blood testing products in home care settings
- 5.3. Market Disruption Analysis
- 5.4. Porter’s Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
- 6. Blood Testing Market, by Type
- 6.1. Introduction
- 6.2. Basic Metabolic Panels
- 6.3. Complete Blood Count Tests
- 6.4. Complete Metabolic Panels
- 6.5. Electrolyte Panels
- 7. Blood Testing Market, by Application
- 7.1. Introduction
- 7.2. Allergies
- 7.3. Autoimmune Diseases
- 7.4. Cancer/Noncancerous Blood Disorders
- 7.5. Endocrine System Disorders
- 7.6. Heart Diseases
- 8. Blood Testing Market, by End-User
- 8.1. Introduction
- 8.2. Home Care
- 8.3. Hospital & Clinics
- 9. Americas Blood Testing Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Blood Testing Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Blood Testing Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Labcorp Launches 3-Part Blood Test for Alzheimer's
- 12.3.2. Bert Vogelstein’s Latest Blood Testing Startup Gets Acquired for USD 450 Million
- 12.3.3. Diagnostics Companies Enter Agreement to Expand Access to Blood-Based IsoPSA Test
- 12.4. Strategy Analysis & Recommendation
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.2. Key Product Portfolio
- FIGURE 1. BLOOD TESTING MARKET RESEARCH PROCESS
- FIGURE 2. BLOOD TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. BLOOD TESTING MARKET DYNAMICS
- FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 22. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.